Delivering The Full Value Chain For Oncology Clinical Trials
By Tim Roberts, Vice President, Global Sales, Clinical Services, PCI Pharma Services
The incidence of cancer is increasing across the globe, and pharmaceutical companies are responding with a pipeline of novel therapeutic candidates. Oncology clinical trials are always challenging, and clinical approaches and the needs for supportive services continue to evolve. Partnering with the right contract services organization that is committed to putting patients first is critical. To ensure the right patients get the right doses of the right medicines every time, even for the most advanced and complex next-generation clinical trial materials, those partners should also continually invest in innovation and have a demonstrated track record of performance, the necessary specialized expertise and capabilities, and a global distribution network.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.